TP 101 - Tract Bio
Alternative Names: TP-101 - Tract BioLatest Information Update: 15 Jan 2024
At a glance
- Originator Tract Bio
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 29 Nov 2023 Tract Bio plans to submit an IND application in Gastric cancer by 2025 (Tract Bio pipeline, November 2023)
- 29 Nov 2023 Tract Bio plans clinical trials in Solid tumours (Tract Bio pipeline, November 2023)
- 01 Nov 2023 Preclinical trials in Solid tumours in USA (Parenteral) prior to November 2023 (Tract Bio pipeline, November 2023)